V

Veracyte

D
VCYT
USD
1.51
(4.4727%)
Market Closed
56,909.00
Volume
0.05
EPS
-
Div Yield
-47.662162
P/E
2,709,163,613.48
Market Cap
Today
4.4727%
1 Week
15.943%
1 Month
9.127%
6 Months
62.835%
12 Months
46.227%
Year To Date
28.208%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
E
EXAS
1.61
(2.3256%)
USD
G
GH
0.3
(1.1952%)
USD
R
RGEN
3.65
(2.5688%)
USD
TMO
TMO
10.31
(1.6903%)
USD
I
ILMN
3.34
(2.5496%)
USD
N
NVTA
(%)
USD
P
PRAH
(%)
USD
D
DGX
-0.37
(-0.238%)
USD
N
NEO
0.31
(1.9183%)
USD
Q
QGEN
-0.09
(-0.197%)
USD

Title:
Veracyte

Sector:
Healthcare
Industry:
Diagnostics & Research
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.
Do you need help or have a question?
Contact Us